Skip to main content

Peer Review reports

From: Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: activity and safety results from a phase II study

Original Submission
9 Dec 2013 Submitted Original manuscript
30 Dec 2013 Author responded Author comments - Jean-Yves Blay
Resubmission - Version 2
30 Dec 2013 Submitted Manuscript version 2
23 Jan 2014 Reviewed Reviewer Report - Anita Wolfer
27 Jan 2014 Reviewed Reviewer Report - Michael Knauer
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
20 Feb 2014 Editorially accepted
7 Mar 2014 Article published 10.1186/1471-2407-14-166

You can find further information about peer review here.

Back to article page